| Pharmaceutical active ingredients: |
| Xylometazoline Hydrochloride |
| Available forms, composition and doses of Nasasinutab: |
| N / A |
| Nasasinutab medical category: |
| Human:Nasal decongestants and other nasal preparationsOphthalmic decongestants, anesthetics, anti-inflammatoriesVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AA07 - XylometazolineR01AB06 - XylometazolineS01GA03 - Xylometazoline |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pfizer |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nasanal | Aluminum Acetotartrate; Pumilio Pine Oil | Brady C. |
| Nasapert | Brompheniramine Maleate; Phenylpropanolamine Hydrochloride | AstraZeneca; Continental Pharma |
| Nasarel | Nafarelin Acetate | Dabur Pharmaceuticals |
| Nasarel | Fluticasone Propionate | IVAX |
| Nasarox | Oxymetazoline Hydrochloride | Schering-Plough |
| Nasatab LA | Guaifenesin; Pseudoephedrine Hydrochloride | ECR Pharmaceuticals |
| Nasatapp | Brompheniramine Maleate; Phenylpropanolamine Hydrochloride | Prohealth Vitamins; Metro Drug Distribution |
| Nasathera Capsules | Acetaminophen; Phenylpropanolamine | Morishita-Seggs Pharmaceuticals; Metro Drug Distribution |
| Nasathera CPM | Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | Morishita-Seggs Pharmaceuticals; Metro Drug Distribution |
| Nasathera P | Phenylpropanolamine Hydrochloride | Morishita-Seggs Pharmaceuticals; Metro Drug Distribution |